DS102

DRUG3 trials

Sponsors

DS Biopharma, Afimmune

Conditions

Chronic Obstructive Pulmonary DiseaseHealthyHypertriglyceridemiaType 2 Diabetes

Phase 1

Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects

CompletedNCT02673593

DS BiopharmaHealthy

Start: 2015-07-31End: 2015-12-31Updated: 2016-02-04

Phase 2

Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT03414541

AfimmuneChronic Obstructive Pulmonary Disease

Start: 2017-09-24End: 2019-01-29Updated: 2020-01-31

Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes

TerminatedNCT04365400

AfimmuneHypertriglyceridemia, Type 2 Diabetes

Start: 2020-10-13End: 2022-05-03Updated: 2023-06-12